Campany says it expects to see decisions from regulators on its protein\u002Dbased vaccine candidate in \u0027weeks\u0027
Novavax Inc has also filed an application for emergency use of its COVID-19 vaccine to the European Medicines Agency. The company said it has completed the submission of all data and modules to the EMA to support the final regulatory review.
The World Health Organization is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, chief executive Stanley Erck told Reuters on Monday. Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.
SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.Article content
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Five million dead (and rising) since COVID-19 emerged in Wuhan, China two years agoVaccines cut fatality rates but case numbers continue to go up, possibly as immunity wanes from doses administered in spring
Read more »
Blackhawks' Patrick Kane cleared to return from COVID-19 protocolThe Chicago Blackhawks announced that forward Patrick Kane, along with assistant coaches Tomas Mitell and Matt Meacham, have returned from COVID-19 protocol.
Read more »
Russian region extends off-work order as COVID-19 cases soarAuthorities in Russia's Novgorod region on Monday ordered most residents to stay off work for one more week starting Nov. 8 as coronavirus infections and deaths remained at all-time highs.
Read more »